Evaluation of Lung Metastases Based on Ultrashort Echo Time MRI

Completed

• Conditions: Hepatoblastoma; Radiology

• Registration Number: NCT05763173
• Lead Sponsor: RenJi Hospital

Brief Summary

Analyze the diagnostic efficiency (including performance, diameter, and location of nodules) of UTE-MRI in lung metastases of hepatoblastoma with chest CT as gold standard

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-01
• Study First Submitted: 2023-02-28
• Study First Submitted QC: 2023-02-28
• Study First Posted: 2023-03-10
• Primary Completion: 2024-02-29
• Study Completion: 2024-02-29
• Status Verified: 2024-04
• Last Update Submitted: 2024-04-16
• Last Update Posted: 2024-04-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 65

Inclusion Criteria

• Children diagnosed as hepatoblastoma (including treated with neoadjuvant chemotherapy but not surgery)
• Recent chest CT scan (within 14 days)
• No MRI contraindications
• The guardian of the children are willing to undergo the examination after full communication and informed consent

Exclusion Criteria

• MRI contraindications (including but not limited to: contrast medium allergy; Claustrophobia;Metal implants;chronic kidney disease≥stage 3 (glomerular filtration rate < 60 mL min-1 (1.73 m2)-1))
• Patients with hepatoblastoma aged 14 years and above
• Children after surgery for hepatoblastoma
• Application of any contrast medium within 24 h before the MRI and/or CT examinations
• There is a concomitant medical condition (e.g. poorly controlled hypertension, severe diabetes, neurological or psychiatric illness, etc.) or any other condition that would seriously endangers the subject's safety, may confuse the study results, or may interfere with the subject's completion of the study according to the investigator's judgment.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
UTE-MRI assessment of lung metastases with chest CT as gold standard	Baseline to 14 days	Analyze the diagnostic efficiency (including performance, diameter, and location of nodules) of UTE-MRI in lung metastases of hepatoblastoma.

Trial Locations

Locations (1)

Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiaotong University; 🇨🇳 Shanghai, Shanghai, China